Nevertheless, an extensive evaluation of the prevalence of the BRCA1 mutation in TN and HR(−) tumors similar to that performed in the British population [37] is needed for proper genetic counseling of individuals and families at higher risk of breast cancer in Brazil. This evidence concerns the gene BRCA1 and breast carcinoma.